These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34345413)

  • 1. Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: the SAFE study.
    Vandenbosch I; Dejongh S; Claes K; Bammens B; De Vusser K; Van Craenenbroeck A; Kuypers D; Evenepoel P; Meijers B
    Clin Kidney J; 2021 Aug; 14(8):1901-1907. PubMed ID: 34345413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
    Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
    Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.
    François K; Wissing KM; Jacobs R; Boone D; Jacobs K; Tielemans C
    BMC Nephrol; 2014 Jul; 15():104. PubMed ID: 24993584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialyzer Performance During Hemodialysis Without Systemic Anticoagulation Using a Heparin-Grafted Dialyzer Combined With a Citrate-Enriched Dialysate: Results of the Randomized Crossover Noninferiority EvoCit Study.
    François K; De Clerck D; Tonnelier A; Cambier ML; Orlando C; Jochmans K; Cools W; Wissing KM
    Am J Kidney Dis; 2022 Jan; 79(1):79-87.e1. PubMed ID: 33940113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
    Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrate-Buffered Dialysis Solution (Citrasate) Allows Avoidance of Anticoagulation During Intermittent Hemodiafiltration-At the Cost of Decreased Performance and Systemic Biocompatibility.
    Richtrova P; Mares J; Kielberger L; Trefil L; Eiselt J; Reischig T
    Artif Organs; 2017 Aug; 41(8):759-766. PubMed ID: 27859427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.
    Islam MS; Hassan ZA; Chalmin F; Vido S; Berrada M; Verhelst D; Donnadieu P; Moranne O; Esnault VL
    Am J Kidney Dis; 2016 Nov; 68(5):752-762. PubMed ID: 27344212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-free regional anticoagulation of haemodialysis filters with calcium-free dialysate: is citrate mandatory?
    Medrano C; Cointault O; Lavayssiere L; Nogier MB; Colliou E; Setbon N; Kamar N; Faguer S
    Clin Kidney J; 2021 Dec; 14(12):2534-2538. PubMed ID: 34950464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple citrate anticoagulation protocol for low flux haemodialysis.
    Lim EK; Seow YT; Chen SE; Yang G; Liaw ME; Isaac S
    BMC Nephrol; 2018 Jan; 19(1):16. PubMed ID: 29351783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate.
    Evenepoel P; Maes B; Vanwalleghem J; Kuypers D; Messiaen T; Vanrenterghem Y
    Am J Kidney Dis; 2002 Feb; 39(2):315-23. PubMed ID: 11840372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate anticoagulation using ACD solution A during long-term haemodialysis.
    Wright S; Steinwandel U; Ferrari P
    Nephrology (Carlton); 2011 May; 16(4):396-402. PubMed ID: 21054668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trial.
    Rossignol P; Dorval M; Fay R; Ros JF; Loughraieb N; Moureau F; Laville M
    Trials; 2013 Jun; 14():163. PubMed ID: 23725299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
    Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
    Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of enoxaparin in preventing coagulation during high-flux haemodialysis, expanded haemodialysis and haemodiafiltration.
    Santos A; Macías N; Vega A; Abad S; Linares T; Aragoncillo I; Cruzado L; Pascual C; Goicoechea M; López-Gómez JM
    Clin Kidney J; 2021 Apr; 14(4):1120-1125. PubMed ID: 33841857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrate pharmacokinetics at high levels of circuit citratemia during coupled plasma filtration adsorption.
    Mariano F; Morselli M; Holló Z; Agostini F; Stella M; Biancone L
    Nephrol Dial Transplant; 2015 Nov; 30(11):1911-9. PubMed ID: 26311056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
    Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study comparing the efficiency of a novel asymmetric cellulose triacetate (ATA) dialyser membrane (Solacea-190H) to a standard high flux polysulfone dialyser membrane (FX-80) in the setting of extended hours haemodialysis.
    Kameshwar K; Damasiewicz MJ; Polkinghorne KR; Kerr PG
    Nephrology (Carlton); 2022 Jun; 27(6):494-500. PubMed ID: 35195932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional citrate anticoagulation in hemodialysis: an observational study of safety, efficacy, and effect on calcium balance during routine care.
    Singer RF; Williams O; Mercado C; Chen B; Talaulikar G; Walters G; Roberts DM
    Can J Kidney Health Dis; 2016; 3():22. PubMed ID: 27099775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
    Skagerlind MSE; Stegmayr BG
    Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.